首页> 外国专利> TSIANOIZOHINOLINOVYE COMPOUND (VARIANTS) PHARMACEUTICAL COMPOSITION ON THEIR BASIS METHOD FOR INHIBITING ACTIVITY hydroxylase Hypoxia-Inducible Factor (HIF) and methods of treatment and / or prophylaxis of conditions associated with HIF and / or condition associated with erythropoietin and / or anemia

TSIANOIZOHINOLINOVYE COMPOUND (VARIANTS) PHARMACEUTICAL COMPOSITION ON THEIR BASIS METHOD FOR INHIBITING ACTIVITY hydroxylase Hypoxia-Inducible Factor (HIF) and methods of treatment and / or prophylaxis of conditions associated with HIF and / or condition associated with erythropoietin and / or anemia

机译:TIANOIZOOHINOLINOVYE化合物(多种)抑制活性的基础方法羟化酶缺氧诱导因子(HIF)以及治疗和/或预防与HIF有关的疾病和/或与促红细胞生成素和/或贫血有关的疾病的方法

摘要

1. Cyanoisoquinoline compounds covered by the general structural formula I:! ! where R is selected from the group consisting of hydrogen, alkyl and substituted alkyl,! R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, amino, substituted amino, -OR7, -SR7, -SOR7 and -SO2R7, where R7 is selected from the group consisting of alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl,! R5 and R6 are independently selected from the group consisting of hydrogen or C1-C3 alkyl,! or their pharmaceutically acceptable salts, tautomers, stereoisomers, solvates and / or prodrugs. ! 2. The compounds according to claim 1, in which at least two of R1, R2, R3 and R4 are hydrogen. ! 3. The compounds according to claim 1, in which R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, hydroxy, halogen, substituted alkyl, aryl, -OR7, -SR7 and -SO2R7, where R7 is selected from the group including alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl. ! 4. The compounds according to claim 3, in which R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, halogen, haloalkyl, alkyl, alkoxy, aryloxy and substituted aryloxy. ! 5. The compounds according to claim 3, in which R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, hydroxy, phenyl, chloro, trifluoromethyl, benzyl, benzyloxy, methoxy, butoxy, isopropoxy, phenoxy, 4-fluorophenoxy, 2 -methoxyphenoxy, 3-methoxyphenoxy, 4-methoxyphenoxy, 2,6-dimethylphenoxy, 2-ethyl-6-methylphenoxy, 2,4,6-trimethylphenoxy, 4-chloro-2,6-dimethylphenoxy, 4-propoxyphenoxy, 2,3 -dihydrobenzo-furan-5-yloxy, 2-methylbenzothiazol-6-yloxy, 2-dimethylaminobenzoxaz
机译:1.氰基异喹啉化合物的结构通式为I :! !其中R选自氢,烷基和取代的烷基,! R1,R2,R3和R4独立地选自氢,卤素,氰基,羟基,烷基,取代的烷基,芳基,取代的芳基,杂芳基,取代的杂芳基,氨基,取代的氨基,-OR7,-SR7,- SOR7和-SO 2 R 7,其中R 7选自烷基,取代的烷基,环烷基,取代的环烷基,芳基,取代的芳基,杂芳基和取代的杂芳基。 R 5和R 6独立地选自氢或C 1 -C 3烷基。或其药学上可接受的盐,互变异构体,立体异构体,溶剂化物和/或前药。 ! 2.根据权利要求1的化合物,其中R1,R2,R3和R4中的至少两个是氢。 ! 3.根据权利要求1的化合物,其中R1,R2,R3和R4独立地选自氢,羟基,卤素,取代的烷基,芳基,-OR7,-SR7和-SO2R7,其中R7选自选自烷基,取代的烷基,环烷基,芳基,取代的芳基,杂芳基和取代的杂芳基。 ! 4.根据权利要求3的化合物,其中R1,R2,R3和R4独立地选自氢,卤素,卤代烷基,烷基,烷氧基,芳氧基和取代的芳氧基。 ! 5.根据权利要求3的化合物,其中R1,R2,R3和R4独立地选自氢,羟基,苯基,氯,三氟甲基,苄基,苄氧基,甲氧基,丁氧基,异丙氧基,苯氧基,4-氟苯氧基,2-甲氧基苯氧基,3-甲氧基苯氧基,4-甲氧基苯氧基,2,6-二甲基苯氧基,2-乙基-6-甲基苯氧基,2,4,6-三甲基苯氧基,4-氯-2,6-二甲基苯氧基,4-丙氧基苯氧基, 2,3-二氢苯并呋喃-5-基氧基,2-甲基苯并噻唑-6基氧基,2-二甲基氨基苯并恶唑

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号